Who owns INMED PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Inmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Inmed Pharmaceuticals stock

Who bought or sold INMED PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Citadel Advisors 57k $13k 368% Sep 2024
 View chart
Renaissance Technologies 50k $12k 100% Sep 2024
 View chart
Hrt Financial 38k $8.0k 140% Sep 2024
 View chart
Virtu Financial 28k $7.0k -67% Sep 2024
 View chart
Baader Bank 23k $3.8k 100% Sep 2024
 View chart
Qube Research & Technologies 200.00 $54.000000 0% Jun 2024
 View chart
Banque Cantonale Vaudoise 125.00 $0 100% Sep 2024
 View chart
Bank of America Corporation 100.00 $24.000000 0% Sep 2024
 View chart
Advisor Group Holdings 27.00 $5.000400 -34% Sep 2024
 View chart
Royal Bank of Canada 24.00 $0 -4% Sep 2024
 View chart
AllSquare Wealth Management 21.00 $5.999700 0% Jun 2024
 View chart
Federation des caisses Desjardins du Quebec 19.00 $5.000800 100% Sep 2024
 View chart
Global Retirement Partners 6.00 $1.000200 0% Sep 2024
 View chart
Gables Capital Management 1.00 $0 0% Sep 2024
 View chart

Who sold out of Inmed Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Armistice Capital Mar 2024 267k $97k
XTX Topco Jun 2024 18k $4.7k
Two Sigma Securities Mar 2024 15k $5.6k
TD Waterhouse Canada Jun 2024 85.00 $21.003500
Toronto-Dominion Bank Jun 2024 2.00 $1.000000